0001380106-23-000116.txt : 20230515 0001380106-23-000116.hdr.sgml : 20230515 20230512191959 ACCESSION NUMBER: 0001380106-23-000116 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPID MICRO BIOSYSTEMS, INC. CENTRAL INDEX KEY: 0001380106 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40592 FILM NUMBER: 23917787 BUSINESS ADDRESS: STREET 1: 1001 PAWTUCKET BLVD. CITY: LOWELL STATE: MA ZIP: 01854 BUSINESS PHONE: 978-349-3200 MAIL ADDRESS: STREET 1: 1001 PAWTUCKET BLVD. CITY: LOWELL STATE: MA ZIP: 01854 FORMER COMPANY: FORMER CONFORMED NAME: RAPID MICRO BIOSYSTEMS INC DATE OF NAME CHANGE: 20061103 10-K/A 1 rmb-20221231.htm 10-K/A rmb-20221231
00013801062022FYTrue00013801062022-01-012022-12-3100013801062022-06-30iso4217:USD0001380106us-gaap:CommonClassAMember2023-03-07xbrli:shares0001380106us-gaap:CommonClassBMember2023-03-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
AMENDMENT NO. 1
(Mark One)
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO
Commission File Number: 001-40592
Rapid Micro Biosystems, Inc.
(Exact name of Registrant as specified in its Charter)
Delaware20-8121647
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
1001 Pawtucket Boulevard West, Suite 280
Lowell, MA
01854
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (978) 349-3200
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange
on which registered
Class A common stock, $0.01 par value
per share
RPID
The Nasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes o No x
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes o No x
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer oAccelerated filer o
Non-accelerated filerxSmaller reporting company x
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. o

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statement. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO x

The aggregate market value of Class A common stock held by non-affiliates of the registrant computed by reference to the price of the registrant’s Class A common stock as of the last business day of the registrant’s most recently completed second fiscal quarter (based on the last reported sale price on The Nasdaq Global Select Market as of such date) was 24,145,209.
The number of shares of the registrant’s Class A common stock, par value $0.01, outstanding as of March 7, 2023 was 36,635,108.
The number of shares of the registrant’s Class B common stock, par value $0.01, outstanding as of March 7, 2023 was 5,553,379.
Our independent public accounting firm is PricewaterhouseCoopers LLP, Boston, Massachusetts (PCAOB ID 238).
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive Proxy Statement relating to its 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 are incorporated herein by reference in Part III.


EXPLANATORY NOTE
Rapid Micro Biosystems, Inc. (the “Company”) is filing this Amendment No. 1 (the “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2023 (the “Original 10-K”), solely for the purpose of filing revised versions of Exhibits 31.1 and 31.2 filed with the Original 10-K.

The Company is filing revised Exhibits 31.1 and 31.2 solely in order to include certification language that was inadvertently omitted from such exhibits when originally filed: (i) the introductory language in paragraph 4 that refers to the certifying officer’s responsibility for establishing and maintaining internal control over financial reporting for the Company; and (ii) paragraph 4(b) regarding the design of internal control over financial reporting. The Amendment does not reflect events occurring after the date of the filing of the Original 10-K or modify or update any of the other disclosures contained therein in any way. Accordingly, the Amendment should be read in conjunction with the Original 10-K. The Amendment consists solely of the preceding cover page, this explanatory note, the signature page and paragraphs 1, 2, 4 and 5 of each of the revised certifications filed as exhibits to the Amendment.

Item 15. Exhibits and Financial Statement Schedules
(a)(3) Exhibits.
The following exhibits are filed as part of this Amendment.
EXHIBIT INDEX
______________________________
*            Filed herewith.



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
RAPID MICRO BIOSYSTEMS, INC.
Date: May 12, 2023
By:/s/ Robert Spignesi
Robert Spignesi
President and Chief Executive Officer

RAPID MICRO BIOSYSTEMS, INC.
Date: May 12, 2023
By:/s/ Sean Wirtjes
Sean Wirtjes
Chief Financial Officer


 EX-31.1 2 rpid-20221231xex311_10ka.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULES 13a-14(a) OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert Spignesi, certify that:
1.I have reviewed this Annual Report on Form 10-K of Rapid Micro Biosystems, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.[Intentionally omitted];
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 12, 2023
By: /s/ Robert Spignesi
Name:Robert Spignesi
Title:Chief Executive Officer
(principal executive officer)

 EX-31.2 3 rpid-20221231xex312_10ka.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULES 13a-14(a) OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Sean Wirtjes, certify that:
1.I have reviewed this Annual Report on Form 10-K of Rapid Micro Biosystems, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.[Intentionally omitted];
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 12, 2023
By:/s/ Sean Wirtjes
Name:Sean Wirtjes
Title:Chief Financial Officer
(principal financial officer and principal accounting officer)

 EX-101.SCH 4 rmb-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 rmb-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 rmb-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line Two Entity Address, Address Line Two Auditor Name Auditor Name Entity Address, Address Line One Entity Address, Address Line One Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Entity Shell Company Entity Shell Company Trading Symbol Trading Symbol Entity File Number Entity File Number Class B Common Stock Common Class B [Member] Auditor Location Auditor Location Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Document Fiscal Year Focus Document Fiscal Year Focus Entity Public Float Entity Public Float Entity Filer Category Entity Filer Category Entity Address, Postal Zip Code Entity Address, Postal Zip Code Class of Stock [Domain] Class of Stock [Domain] Document Fiscal Period Focus Document Fiscal Period Focus City Area Code City Area Code Document Information [Line Items] Document Information [Line Items] Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Auditor [Abstract] Auditor Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Current Fiscal Year End Date Current Fiscal Year End Date Document Period End Date Document Period End Date Document Annual Report Document Annual Report Entity Tax Identification Number Entity Tax Identification Number ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Auditor Firm ID Auditor Firm ID Amendment Description Amendment Description Entity Current Reporting Status Entity Current Reporting Status Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Class A Common Stock Common Class A [Member] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Cover [Abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Document Type Document Type Entity Ex Transition Period Entity Ex Transition Period Document Information [Table] Document Information [Table] Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province EX-101.PRE 7 rmb-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 07, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-40592    
Entity Registrant Name Rapid Micro Biosystems, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 20-8121647    
Entity Address, Address Line One 1001 Pawtucket Boulevard West,    
Entity Address, Address Line Two Suite 280    
Entity Address, City or Town Lowell    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 01854    
City Area Code 978    
Local Phone Number 349-3200    
Title of 12(b) Security Class A common stock, $0.01 par valueper share    
Trading Symbol RPID    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 24,145,209
Documents Incorporated by Reference Portions of the registrant’s definitive Proxy Statement relating to its 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 are incorporated herein by reference in Part III.    
Amendment Description Rapid Micro Biosystems, Inc. (the “Company”) is filing this Amendment No. 1 (the “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2023 (the “Original 10-K”), solely for the purpose of filing revised versions of Exhibits 31.1 and 31.2 filed with the Original 10-K.The Company is filing revised Exhibits 31.1 and 31.2 solely in order to include certification language that was inadvertently omitted from such exhibits when originally filed: (i) the introductory language in paragraph 4 that refers to the certifying officer’s responsibility for establishing and maintaining internal control over financial reporting for the Company; and (ii) paragraph 4(b) regarding the design of internal control over financial reporting. The Amendment does not reflect events occurring after the date of the filing of the Original 10-K or modify or update any of the other disclosures contained therein in any way. Accordingly, the Amendment should be read in conjunction with the Original 10-K. The Amendment consists solely of the preceding cover page, this explanatory note, the signature page and paragraphs 1, 2, 4 and 5 of each of the revised certifications filed as exhibits to the Amendment.    
Entity Central Index Key 0001380106    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag true    
Auditor Location Boston, Massachusetts    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding (in shares)   36,635,108  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding (in shares)   5,553,379  
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Audit Information
 12 Months Ended
Dec. 31, 2022
Auditor [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP,
Auditor Location Boston, Massachusetts
XML 10 rmb-20221231_htm.xml IDEA: XBRL DOCUMENT 0001380106 2022-01-01 2022-12-31 0001380106 2022-06-30 0001380106 us-gaap:CommonClassAMember 2023-03-07 0001380106 us-gaap:CommonClassBMember 2023-03-07 iso4217:USD shares 0001380106 2022 FY true 10-K/A true 2022-12-31 --12-31 false 001-40592 Rapid Micro Biosystems, Inc. DE 20-8121647 1001 Pawtucket Boulevard West, Suite 280 Lowell MA 01854 978 349-3200 Class A common stock, $0.01 par valueper share RPID NASDAQ No No Yes Yes Non-accelerated Filer true true false false false 24145209 36635108 5553379 PricewaterhouseCoopers LLP, Boston, Massachusetts 238 Portions of the registrant’s definitive Proxy Statement relating to its 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 are incorporated herein by reference in Part III. Rapid Micro Biosystems, Inc. (the “Company”) is filing this Amendment No. 1 (the “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2023 (the “Original 10-K”), solely for the purpose of filing revised versions of Exhibits 31.1 and 31.2 filed with the Original 10-K.The Company is filing revised Exhibits 31.1 and 31.2 solely in order to include certification language that was inadvertently omitted from such exhibits when originally filed: (i) the introductory language in paragraph 4 that refers to the certifying officer’s responsibility for establishing and maintaining internal control over financial reporting for the Company; and (ii) paragraph 4(b) regarding the design of internal control over financial reporting. The Amendment does not reflect events occurring after the date of the filing of the Original 10-K or modify or update any of the other disclosures contained therein in any way. Accordingly, the Amendment should be read in conjunction with the Original 10-K. The Amendment consists solely of the preceding cover page, this explanatory note, the signature page and paragraphs 1, 2, 4 and 5 of each of the revised certifications filed as exhibits to the Amendment. EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 4 40 1 false 2 0 false 2 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.rapidmicrobio.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.rapidmicrobio.com/role/AuditInformation Audit Information Cover 2 false false All Reports Book All Reports rmb-20221231.htm rmb-20221231.xsd rmb-20221231_def.xml rmb-20221231_lab.xml rmb-20221231_pre.xml rpid-20221231xex311_10ka.htm rpid-20221231xex312_10ka.htm http://xbrl.sec.gov/dei/2022 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rmb-20221231.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 41 }, "contextCount": 4, "dts": { "definitionLink": { "local": [ "rmb-20221231_def.xml" ] }, "inline": { "local": [ "rmb-20221231.htm" ] }, "labelLink": { "local": [ "rmb-20221231_lab.xml" ] }, "presentationLink": { "local": [ "rmb-20221231_pre.xml" ] }, "schema": { "local": [ "rmb-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 48, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 40, "memberCustom": 0, "memberStandard": 2, "nsprefix": "rmb", "nsuri": "http://www.rapidmicrobio.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rmb-20221231.htm", "contextRef": "i4e00bbb9cae84543a60bfee267097e3b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.rapidmicrobio.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rmb-20221231.htm", "contextRef": "i4e00bbb9cae84543a60bfee267097e3b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rmb-20221231.htm", "contextRef": "i4e00bbb9cae84543a60bfee267097e3b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "menuCat": "Cover", "order": "2", "role": "http://www.rapidmicrobio.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rmb-20221231.htm", "contextRef": "i4e00bbb9cae84543a60bfee267097e3b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/AuditInformation", "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "rmb_AuditorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auditor", "label": "Auditor [Abstract]" } } }, "localname": "AuditorAbstract", "nsuri": "http://www.rapidmicrobio.com/20221231", "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "terseLabel": "Class B Common Stock" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.rapidmicrobio.com/role/CoverPage" ], "xbrltype": "stringItemType" } }, "unitCount": 2 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 17 0001380106-23-000116-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001380106-23-000116-xbrl.zip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end